Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-08

FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA has approved a supplemental application for isotretinoin submitted by Mayne Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)